Waljit Dhillo, Professor in Endocrinology & Metabolism, Consultant Endocrinologist and an NIHR Research Professor at Imperial College London has joined KaNDy Therapeutics as a Scientific and Clinical Advisor.

Waljit Dhillo, Professor in Endocrinology & Metabolism, Consultant Endocrinologist and an NIHR Research Professor at Imperial College London has joined KaNDy Therapeutics as a Scientific and [...]

KaNDy Therapeutics announces positive clinical data with lead candidate NT-814 for the treatment of symptoms of the menopause

~Phase Ib/IIa data showed rapid and highly significant reductions in the frequency and severity of hot flashes and the number of night time awakenings~ ~NT-814 is being developed to provide a [...]

KaNDy Therapeutics Managing Director to present at The Anglonordic Life Science Conference

24th May 2018: KaNDy Therapeutics Managing Director, Dr Mary Kerr, is invited to present at The Anglonordic Life Science Conference 11:00am -12.30pm in the Biotech Investment Room, County Hall, [...]

Dr Mary Kerr presents at the Biotech Showcase, San Francisco

9th January 2018: KaNDy Therapeutics Managing Director, Dr Mary Kerr, presents at the Biotech Showcase, 14:30 Franciscan – C (Ballroom Level), Hilton San Francisco, San Francisco, CA 94102, USA

Mary Kerr MD KaNDy Therapeutics guest speaker at a recent Labiotech meeting in London

Say Hello to the Top 14 Female Entrepreneurs in European Biotech

Press Release: KaNDy Therapeutics launched to focus on a breakthrough new product in Women’s Health

First-in-class once daily NT-814 spun out of NeRRe Therapeutics into new company   Stevenage, UK, 27th September 2017 – KaNDy Therapeutics has been launched today to maximise the value [...]

Contact Us

Please fill out the form to get in touch with us.

Not readable? Change text. captcha txt